[Ip-health] Invite to Press Call regarding March-in Request filed to the NIH by AMSA, KEI, US PIRG, and UAEM

Claire Cassedy claire.cassedy at keionline.org
Mon Sep 16 12:33:07 PDT 2013


Dear All,

On *Wednesday, September 18 at 2pm EST*, KEI will be hosting a press call
to discuss the march-in request filed to the NIH by four groups (AMSA, KEI,
US PIRG and UAEM).  The original request and background information is
available here: http://keionline.org/node/1573 and notes on a follow up
call with the NIH is available here: http://keionline.org/node/1685

Representatives from the American Medical Students Association (AMSA),
Knowledge Ecology International (KEI), U.S. Public Interest Research Group
(PIRG) and the Universities Allied for Essential Medicines (UAEM) will be
on the call.

At the center of the petition is an important policy issue for the NIH. Can
an NIH funded medical invention maintain its patent monopoly when U.S.
residents are paying more than anyone else? The petitioners are asking the
NIH to set a policy that would grant march-in requests when U.S. residents
face substantially higher prices than the patent owners charge in other
countries with comparable incomes. The petition also asks the NIH to adopt
a clear policy on march-in petitions in cases where patents on medical
inventions are “necessary to effect significant health benefits” of a
second product “used or is potentially useful to prevent, treat or diagnose
medical conditions or diseases involving humans.”

*For call-in information or additional questions, please contact *Claire
Cassedy at claire.cassedy at keionline.org or (202)332-2670.

Sincerely,
Claire Cassedy



More information about the Ip-health mailing list